STING agonist-20 structure
|
Common Name | STING agonist-20 | ||
|---|---|---|---|---|
| CAS Number | 2591300-72-8 | Molecular Weight | 753.76 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H39N11O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of STING agonist-20STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1]. |
| Name | STING agonist-20 |
|---|
| Description | STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Jeremy R. DUVALL, et al. Sting agonist compounds and methods of use. US20210032269. |
| Molecular Formula | C36H39N11O8 |
|---|---|
| Molecular Weight | 753.76 |
| InChIKey | BSDFGBNCRMMRDC-BQYQJAHWSA-N |
| SMILES | CCc1nc(C)oc1C(=O)Nc1nc2cc(C(N)=O)cnc2n1CC=CCn1c(NC(=O)c2oc(C)nc2CC)nc2cc(C(N)=O)cc(OCCCO)c21 |